{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR002959",
      "entity_text" : "TNFalpha",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:23725625",
      "entity_text" : "olaparib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Specifically, we showed that olaparib treatment increased the number of intratumoral CD4 + and CD8 + T cells and significantly increased the production of IFNgamma and TNFalpha from these cells.",
  "reading_complete" : "2020-08-09T18:41:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T18:38:14Z",
  "trigger" : "increased",
  "evidence" : [ "olaparib treatment increased the number of intratumoral CD4 +  and CD8 +  T cells and significantly increased the production of IFNgamma and TNFalpha" ],
  "pmc_id" : "6366450",
  "score" : 0
}